The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances responses to anti-PD-1 immunotherapy [CT26]
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
To investigate the imunoresistance programs regulated by the CX3CL1-CX3CR1 axis, we treated CT26 mouse tumor cell line with CX3CL1, CX3CL1 + IFN-?, IFN-?, and no treatment Overall design: Comparative gene expression profiling analysis of RNA-seq data for CT26 tumor cells treated with conditions : CX3CL1, CX3CL1 + IFN-?, IFN-?, and no treatment
创建时间：
2023-12-02
